This does not appear on the adverse event list, is rarely mentioned at the prescribing appointment, and comes up in my inbox more often than almost anything else in this drug class.
It is not really a side effect. It is the reproductive system responding to a metabolic change, which is what it has always done.
Why adipose tissue governs your cycle
Fat is an endocrine organ, not inert storage. It produces oestrogen through aromatisation of androgens, and in large quantities it produces enough to disturb the feedback loop that drives ovulation.
Excess insulin adds a second disruption. High circulating insulin stimulates ovarian androgen production and suppresses sex hormone binding globulin in the liver, raising free testosterone. That combination interferes with follicular development and is the central mechanism in polycystic ovary syndrome.
Reduce the fat mass and the insulin, and both disruptions ease. Follicles develop, ovulation resumes, and a cycle appears.
This is why the reproductive medicine literature has recommended weight loss for anovulatory infertility for decades. What is new is a drug that makes the recommendation achievable at scale.
21–35 days
The range considered a regular adult cycle length
Ovulation first
Fertility returns before any bleed signals it — the egg precedes the period
~3 months
Typical interval before cycle changes become apparent
What people actually report
Cycles becoming regular. The most common account. Someone who bled unpredictably every six to eleven weeks finds themselves on a twenty-eight day pattern, often for the first time since adolescence.
Periods returning. After months or years of absence. This is the one that arrives as a genuine shock, and it is a physiological success being experienced as an alarming event.
A different bleed. Heavier, more painful, more premenstrual symptoms. There is a mechanistic reason: an anovulatory bleed and an ovulatory period are hormonally different events. Resuming ovulation means resuming progesterone production, and with it the cramping and premenstrual pattern that anovulatory cycles do not produce.
Spotting or irregularity during rapid loss. Common in the first few months while the system is recalibrating, and generally settles.
Cycles stopping. Less common, and this one warrants attention rather than reassurance. Very low intake — which is easy to fall into on appetite suppression — can produce functional hypothalamic amenorrhoea, where the body suppresses reproduction because it reads the energy availability as unsafe. That is undereating, not the drug, and the answer is to eat more rather than to accept it. See what to eat on a GLP-1.
The fertility consequence, stated plainly
If you do not want to become pregnant, this is the section that matters.
Irregular periods are not contraception. Absent periods are not contraception. A previous diagnosis of infertility is not contraception. These drugs remove the metabolic obstacle that was suppressing ovulation, and they do it quickly — often before any change in bleeding pattern makes it obvious that ovulation has resumed.
You can ovulate without having had a period first. The egg comes before the bleed.
There is an additional complication for tirzepatide specifically. Mounjaro and Zepbound labelling advises that people using oral contraceptives switch to a non-oral method, or add a barrier method, for four weeks after starting and for four weeks after each dose increase, because delayed gastric emptying can reduce absorption. Six dose steps means six such windows. The full detail is in the four-week rule and drug interactions.
When a change needs looking at
Most cycle changes on this drug class are benign and represent improving metabolic health. Some do not, and the medication is a poor explanation to settle for.
Get assessed for: bleeding between periods, bleeding after sex, any bleeding after the menopause, periods heavy enough to soak through protection hourly or to cause anaemia, severe new pelvic pain, or cycles that stop entirely for three months or more.
Those need a diagnosis. “I started Ozempic” is not one, and attributing a symptom to a medication is one of the more common ways a gynaecological diagnosis gets delayed.
A period returning after four years is the system working. It is also the least convenient possible way to find out that your fertility came back three months ago.
The practical suggestions
Keep a record. Dates, flow, symptoms, alongside your dose. Patterns over months are invisible from memory, and this is exactly the kind of change that is easier to interpret with a log — the case for keeping one is in tracking your GLP-1 journey.
Sort contraception before the first injection, not after the first surprise.
Expect a lag. Cycle changes generally follow meaningful weight loss rather than accompanying the first dose, so month three to six is the usual window.
Watch iron. Heavier periods plus substantially reduced food intake is a reliable route to iron deficiency, which presents as the fatigue people routinely blame on the drug. See supplements for women and supplements for GLP-1 fatigue.
Raise it at appointments. Nobody will ask. Follow-up on these drugs is built around weight, dose and gut symptoms, and this will not come up unless you say it.
Why it goes unmentioned
Partly because it is not a drug effect in the regulatory sense, so it never entered the adverse event tables. Partly because the trials were designed around weight and cardiovascular endpoints. And partly because it is a change in the direction of health, which makes it easy to leave out of a warning list.
None of which helps the person whose period returns after four years with no idea why, or the person who conceives without ever having been told it was possible.